Randomized phase II study of weekly docetaxel versus S-1 and concurrent radiotherapy for stage III and IV laryngeal, oropharyngeal, and hypopharyngeal cancer in elderly patients or patients with complications
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Head and neck cancer; Laryngeal cancer; Oropharyngeal cancer
- Focus Therapeutic Use
- 05 May 2008 New trial record.